153 related articles for article (PubMed ID: 38758859)
21. Identification of miR-210-5p in human placentae from pregnancies complicated by preeclampsia and intrauterine growth restriction, and its potential role in the pregnancy complications.
Awamleh Z; Han VKM
Pregnancy Hypertens; 2020 Jan; 19():159-168. PubMed ID: 32014817
[TBL] [Abstract][Full Text] [Related]
22. First-trimester adiponectin and subsequent development of preeclampsia or fetal growth restriction.
Valdés ER; Lattes KA; Muñoz HS; Barja PY; Papapietro KV
Gynecol Obstet Invest; 2011; 72(3):152-6. PubMed ID: 21912074
[TBL] [Abstract][Full Text] [Related]
23. Characterization of placenta-specific microRNAs in fetal growth restriction pregnancy.
Higashijima A; Miura K; Mishima H; Kinoshita A; Jo O; Abe S; Hasegawa Y; Miura S; Yamasaki K; Yoshida A; Yoshiura K; Masuzaki H
Prenat Diagn; 2013 Mar; 33(3):214-22. PubMed ID: 23354729
[TBL] [Abstract][Full Text] [Related]
24. Exosome-transferred hsa_circ_0014235 promotes DDP chemoresistance and deteriorates the development of non-small cell lung cancer by mediating the miR-520a-5p/CDK4 pathway.
Xu X; Tao R; Sun L; Ji X
Cancer Cell Int; 2020 Nov; 20(1):552. PubMed ID: 33292236
[TBL] [Abstract][Full Text] [Related]
25. Transfer of miR-15a-5p by placental exosomes promotes pre-eclampsia progression by regulating PI3K/AKT signaling pathway via CDK1.
Wang Y; Du X; Wang J
Mol Immunol; 2020 Dec; 128():277-286. PubMed ID: 33197745
[TBL] [Abstract][Full Text] [Related]
26. Plasma Exosomal miR-199a-5p Derived from Preeclampsia with Severe Features Impairs Endothelial Cell Function via Targeting SIRT1.
Chen Z; Wu M; Huang H; Tao H; Zou L; Luo Q
Reprod Sci; 2022 Dec; 29(12):3413-3424. PubMed ID: 36071344
[TBL] [Abstract][Full Text] [Related]
27. First trimester serum angiogenic and anti-angiogenic factors in women with chronic hypertension for the prediction of preeclampsia.
Nzelu D; Biris D; Karampitsakos T; Nicolaides KK; Kametas NA
Am J Obstet Gynecol; 2020 Apr; 222(4):374.e1-374.e9. PubMed ID: 31705883
[TBL] [Abstract][Full Text] [Related]
28. Circulating Exosomal miRNAs as Novel Biomarkers for Stable Coronary Artery Disease.
Zhang P; Liang T; Chen Y; Wang X; Wu T; Xie Z; Luo J; Yu Y; Yu H
Biomed Res Int; 2020; 2020():3593962. PubMed ID: 33381550
[TBL] [Abstract][Full Text] [Related]
29. Cardiovascular Disease-Associated MicroRNA Dysregulation during the First Trimester of Gestation in Women with Chronic Hypertension and Normotensive Women Subsequently Developing Gestational Hypertension or Preeclampsia with or without Fetal Growth Restriction.
Hromadnikova I; Kotlabova K; Krofta L
Biomedicines; 2022 Jan; 10(2):. PubMed ID: 35203467
[TBL] [Abstract][Full Text] [Related]
30. New Predictive Model at 11
Chang Y; Chen X; Cui HY; Li X; Xu YL
Reprod Sci; 2017 May; 24(5):783-789. PubMed ID: 27678097
[TBL] [Abstract][Full Text] [Related]
31. Dysregulated placental microRNAs in Early and Late onset Preeclampsia.
Lykoudi A; Kolialexi A; Lambrou GI; Braoudaki M; Siristatidis C; Papaioanou GK; Tzetis M; Mavrou A; Papantoniou N
Placenta; 2018 Jan; 61():24-32. PubMed ID: 29277268
[TBL] [Abstract][Full Text] [Related]
32. Serum levels of miR-628-3p and miR-628-5p during the early pregnancy are increased in women who subsequently develop preeclampsia.
Martinez-Fierro ML; Carrillo-Arriaga JG; Luevano M; Lugo-Trampe A; Delgado-Enciso I; Rodriguez-Sanchez IP; Garza-Veloz I
Pregnancy Hypertens; 2019 Apr; 16():120-125. PubMed ID: 31056146
[TBL] [Abstract][Full Text] [Related]
33. Identifying late-onset fetal growth restriction by measuring circulating placental RNA in the maternal blood at 28 weeks' gestation.
Whitehead CL; McNamara H; Walker SP; Alexiadis M; Fuller PJ; Vickers DK; Hannan NJ; Hastie R; Tuohey L; Kaitu'u-Lino TJ; Tong S
Am J Obstet Gynecol; 2016 Apr; 214(4):521.e1-521.e8. PubMed ID: 26880734
[TBL] [Abstract][Full Text] [Related]
34. Profiling of cardiovascular and cerebrovascular disease associated microRNA expression in umbilical cord blood in gestational hypertension, preeclampsia and fetal growth restriction.
Hromadnikova I; Kotlabova K; Ivankova K; Vedmetskaya Y; Krofta L
Int J Cardiol; 2017 Dec; 249():402-409. PubMed ID: 29121743
[TBL] [Abstract][Full Text] [Related]
35. Prediction of Early- and Late-Onset Pre-Eclampsia in the Preclinical Stage via Placenta-Specific Extracellular miRNA Profiling.
Timofeeva AV; Fedorov IS; Sukhova YV; Ivanets TY; Sukhikh GT
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175711
[TBL] [Abstract][Full Text] [Related]
36. First-Trimester Screening for Fetal Growth Restriction and Small-for-Gestational-Age Pregnancies without Preeclampsia Using Cardiovascular Disease-Associated MicroRNA Biomarkers.
Hromadnikova I; Kotlabova K; Krofta L
Biomedicines; 2022 Mar; 10(3):. PubMed ID: 35327520
[TBL] [Abstract][Full Text] [Related]
37. Circular RNA hsa_circ_0081343 promotes trophoblast cell migration and invasion and inhibits trophoblast apoptosis by regulating miR-210-5p/DLX3 axis.
Wang H; Luo C; Wu X; Zhang J; Xu Z; Liu Y; Li B; Li J; Xie J
Reprod Biol Endocrinol; 2021 Aug; 19(1):123. PubMed ID: 34365964
[TBL] [Abstract][Full Text] [Related]
38. Angiogenic markers and their longitudinal change for predicting adverse outcomes in pregnant women with chronic hypertension.
Binder J; Kalafat E; Palmrich P; Pateisky P; Khalil A
Am J Obstet Gynecol; 2021 Sep; 225(3):305.e1-305.e14. PubMed ID: 33812812
[TBL] [Abstract][Full Text] [Related]
39. First trimester placental retinol-binding protein 4 (RBP4) and pregnancy-associated placental protein A (PAPP-A) in the prediction of early-onset severe pre-eclampsia.
Yliniemi A; Nurkkala MM; Kopman S; Korpimaki T; Kouru H; Ryynanen M; Marttala J
Metabolism; 2015 Apr; 64(4):521-6. PubMed ID: 25633269
[TBL] [Abstract][Full Text] [Related]
40. Combination of first trimester serum afamin levels and three-dimensional placental bed vascularization as a possible screening method to detect women at-risk for adverse pregnancy complications like pre-eclampsia and gestational diabetes mellitus in low-risk pregnancies.
Tramontana A; Pablik E; Stangl G; Hartmann B; Dieplinger H; Hafner E
Placenta; 2018 Feb; 62():9-15. PubMed ID: 29405972
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
